Abbott Laboratories
ABT · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $7,511,000 | $6,951,000 | $6,532,000 | $7,616,000 |
| Short-Term Investments | $222,000 | $331,000 | $312,000 | $351,000 |
| Receivables | $10,398,000 | $10,232,000 | $7,327,000 | $6,925,000 |
| Inventory | $6,708,000 | $6,954,000 | $6,639,000 | $6,194,000 |
| Other Curr. Assets | $0 | $0 | $2,343,000 | $2,570,000 |
| Total Curr. Assets | $24,839,000 | $24,468,000 | $23,153,000 | $23,656,000 |
| Property Plant & Equip (Net) | $11,504,000 | $11,395,000 | $10,932,000 | $11,733,000 |
| Goodwill | $23,971,000 | $23,952,000 | $23,359,000 | $23,108,000 |
| Intangibles | $5,594,000 | $5,920,000 | $6,261,000 | $6,647,000 |
| Long-Term Investments | $951,000 | $958,000 | $907,000 | $886,000 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $17,318,000 | $17,306,000 | $16,836,000 | $15,384,000 |
| Total NC Assets | $59,338,000 | $59,531,000 | $58,295,000 | $57,758,000 |
| Other Assets | $4,000 | $0 | $0 | $0 |
| Total Assets | $84,181,000 | $83,999,000 | $81,448,000 | $81,414,000 |
| Liabilities | – | – | – | – |
| Payables | $4,123,000 | $4,306,000 | $4,214,000 | $4,195,000 |
| Short-Term Debt | $1,345,000 | $507,000 | $506,000 | $1,754,000 |
| Tax Payable | $469,000 | $390,000 | $485,000 | $594,000 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $8,645,000 | $8,236,000 | $7,799,000 | $7,614,000 |
| Total Curr. Liab. | $14,582,000 | $13,439,000 | $13,004,000 | $14,157,000 |
| LT Debt | $11,596,000 | $12,930,000 | $12,736,000 | $13,521,000 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $1,372,000 |
| Other NC Liab. | $6,739,000 | $6,801,000 | $6,644,000 | $4,463,000 |
| Total NC Liab. | $18,335,000 | $19,731,000 | $19,380,000 | $19,356,000 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $896,000 |
| Total Liabilities | $32,917,000 | $33,170,000 | $32,384,000 | $33,513,000 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $25,412,000 | $25,284,000 | $25,125,000 | $25,153,000 |
| Retained Earnings | $49,103,000 | $48,467,000 | $47,715,000 | $47,261,000 |
| AOCI | -$6,684,000 | -$6,576,000 | -$7,417,000 | -$7,906,000 |
| Other Equity | -$16,877,000 | -$16,610,000 | -$16,612,000 | -$16,844,000 |
| Total Equity | $50,954,000 | $50,565,000 | $48,811,000 | $47,664,000 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $310,000 | $264,000 | $253,000 | $237,000 |
| Total Liab. & Tot. Equity | $84,181,000 | $83,999,000 | $81,448,000 | $81,414,000 |
| Net Debt | $5,430,000 | $6,486,000 | $6,710,000 | $7,659,000 |